"Endometrial Hyperplasia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.
Descriptor ID |
D004714
|
MeSH Number(s) |
C13.351.500.852.228
|
Concept/Terms |
Endometrial Hyperplasia- Endometrial Hyperplasia
- Endometrial Hyperplasias
- Hyperplasia, Endometrial
- Hyperplasias, Endometrial
Atypical Endometrial Hyperplasia- Atypical Endometrial Hyperplasia
- Atypical Endometrial Hyperplasias
- Endometrial Hyperplasia, Atypical
- Endometrial Hyperplasias, Atypical
- Hyperplasia, Atypical Endometrial
- Hyperplasias, Atypical Endometrial
Complex Endometrial Hyperplasia- Complex Endometrial Hyperplasia
- Complex Endometrial Hyperplasias
- Endometrial Hyperplasia, Complex
- Endometrial Hyperplasias, Complex
- Hyperplasia, Complex Endometrial
- Hyperplasias, Complex Endometrial
Simple Endometrial Hyperplasia- Simple Endometrial Hyperplasia
- Endometrial Hyperplasia, Simple
- Endometrial Hyperplasias, Simple
- Hyperplasia, Simple Endometrial
- Hyperplasias, Simple Endometrial
- Simple Endometrial Hyperplasias
|
Below are MeSH descriptors whose meaning is more general than "Endometrial Hyperplasia".
Below are MeSH descriptors whose meaning is more specific than "Endometrial Hyperplasia".
This graph shows the total number of publications written about "Endometrial Hyperplasia" by people in this website by year, and whether "Endometrial Hyperplasia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2000 | 0 | 1 | 1 |
2003 | 2 | 0 | 2 |
2005 | 2 | 1 | 3 |
2007 | 2 | 0 | 2 |
2008 | 3 | 1 | 4 |
2009 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2011 | 1 | 1 | 2 |
2012 | 1 | 0 | 1 |
2013 | 0 | 1 | 1 |
2014 | 1 | 3 | 4 |
2016 | 4 | 0 | 4 |
2017 | 2 | 0 | 2 |
2018 | 2 | 0 | 2 |
2019 | 2 | 0 | 2 |
2020 | 3 | 0 | 3 |
2023 | 1 | 0 | 1 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endometrial Hyperplasia" by people in Profiles.
-
Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion. Clin Cancer Res. 2024 Nov 15; 30(22):5073-5082.
-
Uterine-Conserving Treatment Options for Atypical Endometrial Hyperplasia and Early Endometrial Cancer. Curr Oncol Rep. 2024 Nov; 26(11):1367-1379.
-
Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response. Nat Genet. 2024 Apr; 56(4):637-651.
-
Endometrial cancer patients understanding and interest in weight loss surgery. Gynecol Oncol. 2023 08; 175:88-92.
-
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer. Am J Obstet Gynecol. 2021 02; 224(2):191.e1-191.e15.
-
Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature. Int J Gynecol Pathol. 2020 Jul; 39(4):313-320.
-
Improving response to progestin treatment of low-grade endometrial cancer. Int J Gynecol Cancer. 2020 11; 30(11):1811-1823.
-
National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia. Am J Obstet Gynecol. 2019 11; 221(5):474.e1-474.e11.
-
Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Is Required for Uterine Epithelial Integrity. Am J Pathol. 2019 06; 189(6):1212-1225.
-
Sonic hedgehog protects endometrial hyperplasial cells against oxidative stress via suppressing mitochondrial fission protein dynamin-like GTPase (Drp1). Free Radic Biol Med. 2018 12; 129:582-599.